. Representative images of wound healing assay in BxPC3 cells treated with SA16 and IB35 from Incucyte ZOOM TM assay. Scale bar = 300 μm. Figure S3 . Representative image of a xenograft NOD/SCID mouse treated with IB35 showing the compound deposition on internal organs as evidence of poor solubility and clearance. L, liver; S, spleen.
Whole Blots
Membranes from each gel were cut at different molecular weights (corresponding to the weight of the proteins of interest) and incubated with the corresponding antibodies.
Blot 1: AsPC-1 (A) and HPAF-II (B) cell lysates probed for pAkt (Thr308). The membranes were then stripped and re-probed for total Akt as loading control. Membranes in A and B were exposed for 120 sec for an optimal signal detection while the membranes in C and D were exposed for 30 sec.
Blot 2: AsPC-1 (A) and HPAF-II (B) cell lysates probed for α-actinin as loading control and pAurora A (Thr288)/B (Thr232)/C (Thr198). Membranes in A and B were exposed for 5 as the optimised exposure time to visualise the loading control α-actinin. Five seconds of exposure time, although, was too short to visualise pAurora, which displays a weaker signal. Therefore, we performed a signal accumulation exposure and selected 300 sec as the best exposure time to visualise pAurora in both AsPC-1 (C) and HPAF-II (D).
Blot 3: HPAF-II (A) and AsPC-1 (B) cell lysates probed for α-actinin as loading control and pPLK1 (Thr210. Membranes in A and B were exposed for 6 as the optimised exposure time to visualise the loading control α-actinin. Six seconds of exposure time, although, was too short to visualise pPLK1 (Thr210), which displays a weaker signal. Therefore, we performed a signal accumulation exposure and selected 1300 sec as the best exposure time to visualise pPLK1 in both HPAF-II (C) and AsPC-1 (D).
